发布求助
文献互助 智能选刊 最新文献

CPX-351 （Vyxeos）治疗急性髓系白血病：是时候继续研究了？

IF 10.1 1区 医学 Q1 HEMATOLOGY
American Journal of Hematology Pub Date : 2025-05-29 DOI:10.1002/ajh.27730
Naseema Gangat, Ayalew Tefferi
{"title":"CPX-351 （Vyxeos）治疗急性髓系白血病：是时候继续研究了？","authors":"Naseema Gangat, Ayalew Tefferi","doi":"10.1002/ajh.27730","DOIUrl":null,"url":null,"abstract":"CPX-351 has similar efficacy but more toxicity compared to venetoclax+hypomethylating agent therapy.","PeriodicalId":7724,"journal":{"name":"American Journal of Hematology","volume":"134 1","pages":""},"PeriodicalIF":10.1000,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"CPX-351 (Vyxeos) in Acute Myeloid Leukemia: Time to Move on?\",\"authors\":\"Naseema Gangat, Ayalew Tefferi\",\"doi\":\"10.1002/ajh.27730\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"CPX-351 has similar efficacy but more toxicity compared to venetoclax+hypomethylating agent therapy.\",\"PeriodicalId\":7724,\"journal\":{\"name\":\"American Journal of Hematology\",\"volume\":\"134 1\",\"pages\":\"\"},\"PeriodicalIF\":10.1000,\"publicationDate\":\"2025-05-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of Hematology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1002/ajh.27730\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Hematology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/ajh.27730","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

CPX-351与venetoclax+低甲基化剂治疗相比具有相似的疗效，但毒性更大。
本文章由计算机程序翻译，如有差异，请以英文原文为准。

CPX-351 (Vyxeos) in Acute Myeloid Leukemia: Time to Move on?

分享
查看原文 本刊更多论文
CPX-351 (Vyxeos) in Acute Myeloid Leukemia: Time to Move on?
CPX-351 has similar efficacy but more toxicity compared to venetoclax+hypomethylating agent therapy.
求助全文
通过发布文献求助，成功后即可免费获取论文全文。 去求助
来源期刊
American Journal of Hematology
American Journal of Hematology 医学-血液学
CiteScore
15.70
自引率
3.90%
发文量
363
审稿时长
3-6 weeks
期刊介绍： The American Journal of Hematology offers extensive coverage of experimental and clinical aspects of blood diseases in humans and animal models. The journal publishes original contributions in both non-malignant and malignant hematological diseases, encompassing clinical and basic studies in areas such as hemostasis, thrombosis, immunology, blood banking, and stem cell biology. Clinical translational reports highlighting innovative therapeutic approaches for the diagnosis and treatment of hematological diseases are actively encouraged.The American Journal of Hematology features regular original laboratory and clinical research articles, brief research reports, critical reviews, images in hematology, as well as letters and correspondence.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信